• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国2型糖尿病的诊断年龄:基于6900万人理赔数据的全国性分析。

Age at diagnosis of Type 2 diabetes in Germany: a nationwide analysis based on claims data from 69 million people.

作者信息

Jacobs E, Rathmann W, Tönnies T, Arendt D, Marchowez M, Veith L, Kuss O, Brinks R, Hoyer A

机构信息

Institute for Biometrics and Epidemiology, German Diabetes Centre, Leibniz Centre for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

German Centre for Diabetes Research, München-Neuherberg, Germany.

出版信息

Diabet Med. 2020 Oct;37(10):1723-1727. doi: 10.1111/dme.14100. Epub 2019 Aug 27.

DOI:10.1111/dme.14100
PMID:31390484
Abstract

AIM

For many European countries, including Germany, no valid estimates are available on age at diagnosis of Type 2 diabetes. Thus, we aimed to estimate the age at diagnosis in Germany.

METHODS

Age at diagnosis of Type 2 diabetes in Germany was estimated based on Type 2 diabetes prevalence and incidence and the age distribution of the German population. Age- and sex-specific incidence and prevalence in 2014/2015, based on claims data from statutory health insurance (n= 69 000 000, ~85% of the German population), and the age pyramid for Germany in 2015 were used for the calculation. Age at Type 2 diabetes diagnosis was stratified by sex. CIs were estimated using bootstrap methods. In addition, the age range in which 50% of the population received a diagnosis of Type 2 diabetes was calculated (the interquartile range).

RESULTS

The mean ± sd age at Type 2 diabetes diagnosis in 2015 was 61.0 ± 13.4 years (95% CI 60.9-61.0) in men. Women were diagnosed ~2 years later than men (mean age 63.4 ± 14.9 years; 95% CI 63.4-63.5). The age range in which 50% of the population was diagnosed with diabetes was 53-72 years for men and 54-76 years for women.

CONCLUSIONS

The sex differences are mainly attributable to a higher incidence of Type 2 diabetes in men than women during middle age and the higher absolute number of women in the older ages. The early age at diabetes diagnosis compared to average life expectancy means that the risk of diabetes-related complications is increased.

摘要

目的

对于包括德国在内的许多欧洲国家,尚无关于2型糖尿病诊断年龄的有效估计值。因此,我们旨在估计德国的2型糖尿病诊断年龄。

方法

基于2型糖尿病患病率、发病率以及德国人口的年龄分布来估计德国2型糖尿病的诊断年龄。计算时使用了2014/2015年基于法定医疗保险理赔数据(n = 69000000,约占德国人口的85%)得出的年龄和性别特异性发病率及患病率,以及2015年德国的年龄金字塔。2型糖尿病诊断年龄按性别分层。采用自助法估计置信区间。此外,还计算了50%的人口被诊断为2型糖尿病的年龄范围(四分位间距)。

结果

2015年男性2型糖尿病诊断的平均年龄±标准差为61.0±13.4岁(95%置信区间60.9 - 61.0)。女性的诊断时间比男性晚约2年(平均年龄63.4±14.9岁;95%置信区间63.4 - 63.5)。男性中50%的人口被诊断患有糖尿病的年龄范围是53 - 72岁,女性是54 - 76岁。

结论

性别差异主要归因于中年男性2型糖尿病的发病率高于女性,以及老年女性的绝对数量更多。与平均预期寿命相比,糖尿病诊断年龄较早意味着糖尿病相关并发症的风险增加。

相似文献

1
Age at diagnosis of Type 2 diabetes in Germany: a nationwide analysis based on claims data from 69 million people.德国2型糖尿病的诊断年龄:基于6900万人理赔数据的全国性分析。
Diabet Med. 2020 Oct;37(10):1723-1727. doi: 10.1111/dme.14100. Epub 2019 Aug 27.
2
Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance.德国西南部2型糖尿病的患病率、发病率及合并症——一项基于大型法定医疗保险理赔数据的回顾性队列和病例对照研究
BMC Public Health. 2015 Sep 3;15:855. doi: 10.1186/s12889-015-2188-1.
3
Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.2012 年至 2021 年德国 2 型糖尿病发病趋势:对 1100 万法定参保人健康索赔数据的分析。
Diabetologia. 2024 Jun;67(6):1040-1050. doi: 10.1007/s00125-024-06113-8. Epub 2024 Feb 26.
4
Burden of Mortality Attributable to Diagnosed Diabetes: A Nationwide Analysis Based on Claims Data From 65 Million People in Germany.归因于确诊糖尿病的死亡率负担:基于德国 6500 万人理赔数据的全国性分析。
Diabetes Care. 2017 Dec;40(12):1703-1709. doi: 10.2337/dc17-0954. Epub 2017 Oct 9.
5
[Incidence and prevalence of type 2 diabetes mellitus in Germany: an analysis based on 5.43 million patients].德国2型糖尿病的发病率和患病率:基于543万患者的分析
Dtsch Med Wochenschr. 2013 Jan;138(3):69-75. doi: 10.1055/s-0032-1327394. Epub 2013 Jan 8.
6
Association between regional deprivation and type 2 diabetes incidence in Germany.德国地区贫困与 2 型糖尿病发病率的关系。
BMJ Open Diabetes Res Care. 2019 Dec 17;7(1):e000857. doi: 10.1136/bmjdrc-2019-000857. eCollection 2019.
7
Excess mortality for people diagnosed with type 2 diabetes in 2012 - Estimates based on claims data from 70 million Germans.2012年2型糖尿病确诊患者的超额死亡率——基于7000万德国人的理赔数据估算
Nutr Metab Cardiovasc Dis. 2018 Sep;28(9):887-891. doi: 10.1016/j.numecd.2018.05.008. Epub 2018 May 29.
8
Projected number of people with diagnosed Type 2 diabetes in Germany in 2040.预计 2040 年德国诊断出的 2 型糖尿病患者人数。
Diabet Med. 2019 Oct;36(10):1217-1225. doi: 10.1111/dme.13902. Epub 2019 Feb 13.
9
Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002.系统性红斑狼疮的年龄和性别特异性发病率:基于2002年德国法定医疗保险230万人横断面理赔数据的估计。
Lupus Sci Med. 2016 Nov 25;3(1):e000181. doi: 10.1136/lupus-2016-000181. eCollection 2016.
10
Future number of people with diagnosed type 1 diabetes in Germany until 2040: an analysis based on claims data.未来 2040 年德国被诊断为 1 型糖尿病的人数预测:基于索赔数据的分析。
BMJ Open Diabetes Res Care. 2023 Apr;11(2). doi: 10.1136/bmjdrc-2022-003156.

引用本文的文献

1
[Self-reported cognitive glucose sensitivity: association with long-term blood-glucose-levels and diabetes-related distress in individuals with type 1 diabetes].[自我报告的认知葡萄糖敏感性:与1型糖尿病患者的长期血糖水平及糖尿病相关困扰的关联]
Pravent Gesundh. 2023 Feb 24:1-8. doi: 10.1007/s11553-023-01017-8.
2
Sex differences in intracranial plaque burden in patients with type 2 diabetes mellitus with acute ischemic cerebrovascular disease: a pilot study based on high-resolution MRI.2型糖尿病合并急性缺血性脑血管病患者颅内斑块负荷的性别差异:一项基于高分辨率磁共振成像的初步研究
Front Endocrinol (Lausanne). 2025 Jan 24;15:1417240. doi: 10.3389/fendo.2024.1417240. eCollection 2024.
3
Metabolic and lifestyle factors accelerate disease onset and alter gut microbiome in inflammatory non-communicable diseases.
代谢和生活方式因素会加速炎症性非传染性疾病的发病,并改变肠道微生物组。
BMC Med. 2024 Oct 24;22(1):493. doi: 10.1186/s12916-024-03709-0.
4
The rat as an animal model in chronic wound research: An update.大鼠作为慢性伤口研究中的动物模型:最新进展。
Life Sci. 2024 Aug 15;351:122783. doi: 10.1016/j.lfs.2024.122783. Epub 2024 Jun 5.
5
Hailey-Hailey Disease is Associated with Diabetes: A Population-based Cohort Study, Clinical Cohort Study, and Pedigree Analysis.Hailey-Hailey 病与糖尿病相关:一项基于人群的队列研究、临床队列研究和家系分析。
Acta Derm Venereol. 2023 Nov 28;103:adv10436. doi: 10.2340/actadv.v103.10436.
6
Diabetes in a hospital cohort of persons living with HIV: a descriptive and comparative study in French Guiana.在法属圭亚那的一项针对感染艾滋病毒的人群的医院队列研究中,糖尿病的描述性和对比研究。
BMC Infect Dis. 2023 Jul 13;23(1):470. doi: 10.1186/s12879-023-08455-x.
7
Common procedures and conditions leading to inpatient hospital admissions in adults with and without diabetes from 2015 to 2019 in Germany : A comparison of frequency, length of hospital stay and complications.2015 年至 2019 年德国有和无糖尿病成人住院的常见程序和情况:频率、住院时间和并发症比较。
Wien Klin Wochenschr. 2023 Jul;135(13-14):325-335. doi: 10.1007/s00508-023-02153-z. Epub 2023 Feb 10.
8
Association of age at menopause with type 2 diabetes mellitus in postmenopausal women in the United States: National Health and Nutrition Examination Survey 2011-2018.美国绝经后女性绝经年龄与2型糖尿病的关联:2011 - 2018年国家健康和营养检查调查
Prz Menopauzalny. 2022 Dec;21(4):229-235. doi: 10.5114/pm.2022.123514. Epub 2022 Dec 30.
9
Cellular enlargement - A new hallmark of aging?细胞增大——衰老的一个新标志?
Front Cell Dev Biol. 2022 Nov 10;10:1036602. doi: 10.3389/fcell.2022.1036602. eCollection 2022.
10
Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.二肽基肽酶-4抑制剂在老年2型糖尿病患者中的安全性:一项随机对照试验的系统评价和荟萃分析
Ther Adv Drug Saf. 2022 Jan 21;13:20420986211072383. doi: 10.1177/20420986211072383. eCollection 2022.